The conversation is about a person starting treatment with RU58841 for hair loss. They are asked to share progress pictures to show if the treatment is effective.
The conversation is about whether the phase 2 results for pyrilutamide, a potential hair loss treatment, were presented at a dermatology convention and inquiries about the completion of phase 3 trials. Specific treatments mentioned include pyrilutamide.
A user has been using finasteride since 2018, switched to dutasteride, and added minoxidil, microneedling, and a tretinoin/spiro compound. They are pleased with the results and hopeful for more improvement.
Hair loss theories discussed include poor blood flow, scalp tension, inflammation, and DHT. Treatments mentioned are massaging scalp, minoxidil, finasteride, and RU58841.
The post discusses the use of mesotherapy with dutasteride for hair loss treatment, showing before and after photos. The conversation includes mentions of Minoxidil, finasteride, and RU58841 as other treatments.
The conversation is about a hair loss treatment regimen including finasteride, oral minoxidil, Stemoxydine, a multi-peptide serum, and ketoconazole. A suggestion was made to add dermastamping and tretinoin.
Blocking DHT is not a complete solution for hair loss; instead, altering the scalp's response to DHT may be more effective. Topical finasteride and minoxidil are current treatments, but future approaches may involve bioengineering, gene therapy, and inflammation control.
A 22-year-old male experienced significant hair regrowth after 4 months using minoxidil, finasteride, and dermarolling. He reported initial mild testicular pain but no other side effects, and he uses a 1mm and 0.5mm dermaroller.
Kintor Pharma successfully dosed the first patient in a Phase II trial for KX-826 for acne vulgaris. Users are more interested in results for male pattern baldness (MPB).
A new hair loss treatment theory beyond minoxidil and finasteride is proposed, causing mixed reactions in the community, with some members eager to explore and support it, while others call for more research and evidence.